Nanni C; Zamagni E; Celli M; Caroli P; Ambrosini V; Tacchetti P; Brioli A; Zannetti B; Pezzi A; Pantani L; Perrone G; Zompatori M; Cavo M; Colletti PM; Rubello D; Fanti S., The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. e74 - e79 [Scientific article]
Lucconi G.; Cicoria G.; Pancaldi D.; Lodi F.; Malizia C.; Fanti S.; Boschi S.; Marengo M., Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis., «APPLIED RADIATION AND ISOTOPES», 2013, 80, pp. 27 - 31 [Scientific article]
Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti, 11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy, in: Supplement, «THE JOURNAL OF NUCLEAR MEDICINE», 2013, 53, pp. N/A - N/A (atti di: SNMMI Annual Meeting, St. Louis, MI, USA, 14 Giugno 2013) [Abstract]
Ceci F;Castellucci P;Mamede M;SCHIAVINA R.;Rubello D;Fuccio C;Ambrosini V;Boschi S;Martorana G;Fanti S, (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2013, 40, pp. 149 - 155 [Scientific article]
Ceci F; Schiavina R; Castellucci P; Brunocilla E; Fuccio C; Colletti PM; Ferretti A; Chondrogiannis S; Rubello D; Romagnoli D; Malizia C; Martorana G; Fanti S., 11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study., «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. 279 - 282 [Scientific article]
Carmelo Quarta;Filippo Lodi;Roberta Mazza;Ferdinando Giannone;Laura Boschi;Cristina Nanni;Enzo Nisoli;Stefano Boschi;Renato Pasquali;Stefano Fanti;Patricia Iozzo;Uberto Pagotto, 11C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion, «MOLECULAR METABOLISM», 2013, 2, pp. 153 - 160 [Scientific article]Open Access
R. Bonfiglioli;C. Nanni;J. J. Morigi;M. Graziosi;F. Trapani;M. Bartoletti;F. Tumietto;V. Ambrosini;A. Ferretti;D. Rubello;C. Rapezzi;P. L. Viale;S. Fanti, (18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2013, 40, pp. 1190 - 1196 [Scientific article]
Ambrosini V; Zompatori M; Fasano L; Nanni C; Nava S; Rubello D; Fanti S, 18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. 171 - 177 [Scientific article]
Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M., A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma., «ANNALS OF ONCOLOGY», 2012, 23, pp. 415 - 420 [Scientific article]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [Scientific article]
Piccardo A.; Lopci E.; Conte M.; Garaventa A.; Foppiani L.; Altrinetti V.; Nanni C.; Bianchi P.; Cistaro A.; Sorrentino S.; Cabria M.; Pession A.; Puntoni M.; Villavecchia G.; Fanti S., Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 57 - 71 [Scientific article]
Treglia G; Castaldi P; Villani MF; Perotti G; de Waure C; Filice A; Ambrosini V; Cremonini N; Santimaria M; Versari A; Fanti S; Giordano A; Rufini V., Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 569 - 580 [Scientific article]
P. Spinnato; A. Bazzocchi; A. Brioli; C. Nanni; E. Zamagni; U. Albisinni; M. Cavo; S. Fanti; G. Battista; E. Salizzoni, Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. 4013 - 4018 [Scientific article]
Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S., Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 4 - 12 [Scientific article]
Cerci J.J.; Zanoni L.; Meneghetti J.C.; Fanti S., FDG- PET in Lymphoma: Nuclear Medicine Perspective., in: ELSTROM R.L. SCHUSTER S.J., PET imaging of Lymphoma, PHILADELPHIA, W.B. Saunders Company-Elsevier, 2012, pp. 21 - 33 [Chapter or essay]
